metformin has been researched along with No-Reflow Phenomenon in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
No-Reflow Phenomenon: Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggested that chronic pretreatment with metformin may be associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for AMI." | 7.79 | Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction. ( Fan, CM; Gao, X; Pei, WD; Yang, YJ; You, SJ; Zhao, JL; Zhou, Q, 2013) |
| "These results suggested that chronic pretreatment with metformin may be associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for AMI." | 3.79 | Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction. ( Fan, CM; Gao, X; Pei, WD; Yang, YJ; You, SJ; Zhao, JL; Zhou, Q, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, JL | 1 |
| Fan, CM | 1 |
| Yang, YJ | 1 |
| You, SJ | 1 |
| Gao, X | 1 |
| Zhou, Q | 1 |
| Pei, WD | 1 |
1 other study available for metformin and No-Reflow Phenomenon
| Article | Year |
|---|---|
Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Circulation; Diabetes Mellitus, Type 2; Female; Human | 2013 |